OTCMKTS:THRA Therma-Med (THRA) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free THRA Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Therma-Med alerts: Email Address Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. About Therma-Med Stock (OTCMKTS:THRA)Therma-Med Inc. engages in the acquisition, exploration, and development of precious and base metal mineral properties in Canada. It focuses on exploring silver, zinc, and lead hosting mineral claims situated in the Mining Division of Slocan, British Columbia. Therma-Med Inc. was incorporated in 1988 and is based in Beverly Hills, California.Read More Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. THRA Stock News HeadlinesApril 18, 2024 | msn.comX-Therma sees FDA Drug Master File acceptanceMarch 15, 2024 | msn.comX-Therma raises $22.4m to scale cryopreservation devicesFebruary 21, 2024 | msn.comCompare with Therma Bright Inc (THRM)December 5, 2023 | markets.businessinsider.comTherma Bright Provides Update on Cease Trade OrderNovember 15, 2023 | msn.comTherma Mobile donates eye equipment to Navotas HospitalNovember 2, 2023 | markets.businessinsider.comTherma Bright Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United StatesSeptember 8, 2023 | markets.businessinsider.comTherma Bright Submits Updated FDA 510K Application Requesting Correction of Venowave Device's Intended Use, Labeling, and DescriptionAugust 24, 2023 | markets.businessinsider.comTherma Bright Provides Update on Venowave's Permanent CPT/HCPCS Code Application ProcessAugust 5, 2023 | markets.businessinsider.comTherma Bright Provides Update on Venowave's Permanent CPT/HCPCS Codes and United States Distribution PartnersJuly 20, 2023 | forbes.comBest Medical Alert Watches Of 2023June 30, 2023 | markets.businessinsider.comTherma Bright Provides Update on Venowave for the United States and Texas RegionJune 23, 2023 | markets.businessinsider.comTherma Bright Investigates Remote Therapeutic Monitoring (RTM) Reimbursement for its AI-Driven Digital Cough TechnologyJune 7, 2023 | markets.businessinsider.comTherma Bright's Investment Partner Inretio Announces Successful Completion of GLP Study for PREVA(TM) Thrombectomy DeviceApril 14, 2023 | markets.businessinsider.comTherma Bright Secures Medicare and Medicaid Reimbursement for Venowave DeviceFebruary 25, 2023 | finanznachrichten.deTherma Bright Inc.: Therma Bright Reports on Progress of Inretio's Novel Clot Removal Device for Stroke TreatmentFebruary 22, 2023 | theglobeandmail.comTherma Bright: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (THRM)February 18, 2023 | proactiveinvestors.comTherma Bright inks exclusive license agreement for AI4LYF's Digital Cough Technology to detect respiratory diseasesSeptember 22, 2022 | proactiveinvestors.comTherma Bright receives payment for initial Venowave orders in the US; explores global opportunities for the DVT prevention deviceSeptember 20, 2022 | yahoo.comTherma Bright Receives Payment for Initial Venowave SalesJuly 19, 2022 | benzinga.comTherma-Med (OTC:THRA), Earnings Estimates, EPS, and RevenueJune 23, 2022 | finance.yahoo.comTherma Bright Submits Health Canada Application for Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test for Point-of-Care (POC)June 2, 2022 | finance.yahoo.comTherma Bright Provides Update on FDA EUA Application Process For AcuVid(TM) COVID-19 Rapid Antigen Saliva TestJanuary 14, 2022 | nasdaq.comTherma-Med Inc (THRA)See More Headlines Receive THRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Therma-Med and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/31/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBasic Materials Industry Miscellaneous shopping goods stores Sub-IndustryN/A Current SymbolOTCMKTS:THRA CUSIPN/A CIKN/A Webwww.therma-medinc.com Phone(424) 242-6727FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Joshua SuarezChief Executive Officer, President, Secretary, Treasurer & DirectorKey CompetitorsDICK'S Sporting GoodsNYSE:DKSAcademy Sports and OutdoorsNASDAQ:ASOODPNASDAQ:ODPHibbettNASDAQ:HIBBSportsman's WarehouseNASDAQ:SPWHView All Competitors THRA Stock Analysis - Frequently Asked Questions How do I buy shares of Therma-Med? Shares of THRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:THRA) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaElon Musk’s Final Masterpiece: “X-9840”Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Therma-Med, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.